Table 4.
Sensitivity analysis for DMCs, DNMCs, ICs, and total costs of MDD patients in Iran in 2020
| One-way Sensitivity analysis (PPP) | Number of patients in Iran | DMC | DNMC | IC | COI | ||||
|---|---|---|---|---|---|---|---|---|---|
| PPP | USD | PPP | USD | PPP | USD | PPP | USD | ||
| Lower limit | 1,981,210 | 3,966,540,916 | 2,957,589,912 | 405,197,069 | 302,015,652 | 1,012,021,880 | 754,583,452 | 5,383,759,865 | 4,014,189,016 |
| Upper limit | 3,259,410 | 6,525,599,572 | 4,865,712,436 | 666,614,533 | 496,864,460 | 1,664,939,222 | 1,241,411,486 | 8,857,153,327 | 6,603,988,382 |
DMC Direct Medical Costs; DNMC Direct Non-Medical Costs; IC Indirect Costs